Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2019 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (172)	7/28/2019 4:28:03 PM
From: bmaz001	Read Replies (1) \| Respond to of 280

Arthur, It's clear that Bulba felt threatened by your ominous presence in the contest's top 10 list and decided to take matters into his own hands. My double-naught spies have informed me that Bulba recently traveled to Sanofi headquarters to personally convince CEO Olivier Brandicourt to cancel the partnership with LXRX. Here is a photo of Bulba making his case to Brandicourt. The picture doesn't lie, Bulba! You have some 'splaining to do.